Helpful diagnostic markers of steroidogenesis for defining hyperandrogenemia in hirsute women

Steroids

Volumn 73, Issue 1, 2008, Pages 41-46

  Willenberg, Holger S ^a   Bahlo, Maryam ^a   Schott, Matthias ^a   Wertenbruch, Tina ^a   Feldkamp, Joachim ^b   Scherbaum, Werner A ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b OWL University   (Germany)

Author keywords

21 Hydroxylase; Adrenal gland; Congenital adrenal hyperplasia; Hirsutism; Hyperandrogenemia; PCOS

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; ANDROSTENEDIONE; CORTODOXONE; HYDROXYPROGESTERONE; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; STEROID 21 MONOOXYGENASE; TESTOSTERONE; TETRACOSACTIDE;

ADOLESCENT; ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; DIAGNOSTIC VALUE; ENZYME DEFICIENCY; FEMALE; FERRIMAN AND GALLWEY SCORE; HIRSUTISM; HORMONE BLOOD LEVEL; HUMAN; HYDROXYLATION; HYPERANDROGENISM; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PARAMETER; SCORING SYSTEM; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL;

17-ALPHA-HYDROXYPROGESTERONE; ADOLESCENT; ADULT; AGED; ANDROSTENEDIONE; BIOLOGICAL MARKERS; CORTODOXONE; DEHYDROEPIANDROSTERONE; FEMALE; FOLLICLE STIMULATING HORMONE; HIRSUTISM; HUMANS; HYPERANDROGENISM; INSULIN-LIKE GROWTH FACTOR I; LUTEINIZING HORMONE; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; RADIOIMMUNOASSAY; STEROID 21-HYDROXYLASE;

EID: 36849051181     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.08.009     Document Type: Article

References (26)

1. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., and Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83 (1998) 3078-3082
2. Franks S. Polycystic ovary syndrome. N Engl J Med 333 (1995) 853-861
3. Souter I., Sanchez L.A., Perez M., Bartolucci A.A., and Azziz R. The prevalence of androgen excess among patients with minimal unwanted hair growth. Am J Obstet Gynecol 191 (2004) 1914-1920
4. Carmina E., Rosato F., Janni A., Rizzo M., and Longo R.A. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91 (2006) 2-6
5. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
6. Hatch R., Rosenfield R.L., Kim M.H., and Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140 (1981) 815-830
7. Wilson R.C., Mercado A.B., and Cheng K.C. New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 80 (1995) 2322-2329
8. Schram P., Zerah M., Mani P., Jewelewicz R., and Jaffe S. New MI. Nonclassical 3 beta-hydroxysteroid dehydrogenase deficiency: a review of our experience with 25 female patients. Fertil Steril 58 (1992) 129-136
9. Azziz R., Dewailly D., and Owerbach D. Clinical review 56: nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78 (1994) 810-815
10. Sahin Y., and Kelestimur F. 17-Hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17alpha dysregulation. Hum Reprod 12 (1997) 910-913
11. Rosenfield R.L. Clinical practice. Hirsutism. N Engl J Med 353 (2005) 2578-2588
12. Boots L.R., Potter S., Potter D., and Azziz R. Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability. Fertil Steril 69 (1988) 286-292
13. Waggoner W., Boots L.R., and Azziz R. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. Gynecol Endocrinol 13 (1999) 394-400
14. Van Uytfanghe K., Stockl D., Kaufman J.M., Fiers T., De Leenheer A., and Thienpont L.M. Validation of 5 routine assays for serum free testosterone with a candidate reference measurement procedure based on ultrafiltration and isotope dilution-gas chromatography-mass spectrometry. Clin Biochem 38 (2005) 253-261
15. Benjamin F., Deutsch S., Saperstein H., and Seltzer V.L. Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease. Fertil Steril 46 (1986) 215-221
16. Kamel N., Tonyukuk V., Emral R., Corapcioglu D., Bastemir M., and Gullu S. The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia. Endocr J 50 (2003) 815-823
17. Gabrilove J.L., Sharma D.C., and Dorman R.I. Adrenocortical 11-beta-hydroxylase deficiency and virilism first manifest in the adult woman. N Engl J Med. 272 (1965) 1189-1194
18. Chrousos G.P., Loriaux D.L., Mann D.L., and Cutler Jr. G.B. Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. Ann Intern Med 96 (1982) 143-148
19. Hague W.M., Adams J., Rodda C., Brook C.G., de Bruyn R., Grant D.B., and Jacobs H.S. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol 33 (1990) 501-510
20. Eldar-Geva T., Hurwitz A., Vecsei P., Palti Z., Milwidsky A., and Rosler A. Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia. N Engl J Med 323 (1990) 855-863
21. Gatee O.B., Al Attia H.M., and Salama I.A. Hirsutism in the United Arab Emirates: a hospital study. Postgrad Med J 72 (1996) 168-171
22. Pache T.D., Wladimiroff J.W., Hop W.C., and Fauser B.C. How to discriminate between normal and polycystic ovaries: transvaginal US study. Radiology 183 (1992) 421-423
23. Fulghesu A.M., Ciampelli M., Belosi C., Apa R., Pavone V., and Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil Steril 76 (2001) 326-331
24. Sahin Y., and Kelestimur F. 17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome. Clin Endocrinol 39 (1993) 151-155
25. Chang P.L., Lindheim S.R., Lowre C., Ferin M., Gonzalez F., Berglund L., Carmina E., Sauer M.V., and Lobo R.A. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. J Clin Endocrinol Metab 85 (2000) 995-1000
26. Fulghesu A.M., Angioni S., Belosi C., Apa R., Selvaggi L., Ciampelli M., Iuculano A., Melis G.B., and Lanzone A. Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma. Clin Endocrinol 65 (2006) 396-401